Earnings History Data for Corbus Pharmaceuticals Holdings, Inc. (CRBP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
15-03-2021 PM 7:05 AM ET
(Mar 15)
CRBP Corbus Pharmaceuticals Holdings, Inc. 157.15 -0.10 -0.31 -0.41 Corbus Pharmaceuticals EPS beats by $0.13, misses on revenue
[3/15/2021 7:08 AM]
2.26 -0.06 
(-2.79%)
2.38 0.05 
(2.15%)
0.91 - 9.78 8,774,722 7,972,277 355,513
10-11-2020 PM 7:05 AM ET
(Nov 10)
CRBP Corbus Pharmaceuticals Holdings, Inc. 92.33 -0.43 -0.41 -0.32 Corbus Pharmaceuticals EPS misses by $0.02, misses on revenue
[11/10/2020 7:08 AM]
1.22 0.0 
(-0.41%)
1.17 -0.05 
(-4.10%)
0.91 - 9.78 4,445,958 2,796,468 52,930
06-08-2020 PM 7:05 AM ET
(Aug 6)
CRBP Corbus Pharmaceuticals Holdings, Inc. 492.21 -0.52 -0.38 0.03 Corbus Pharmaceuticals EPS misses by $0.14, misses on revenue
[8/6/2020 7:08 AM]
6.40 -0.75 
(-10.49%)
7.10 -0.05 
(-0.70%)
3.29 - 8.78 1,527,415 1,786,776 14,199